title: Canadian integrative oncology research priorities: results of a consensus-building process.
abstract: BACKGROUND
  In Canada, many diverse models of integrative oncology care have emerged in response to the growing number of cancer patients who combine complementary therapies with their conventional medical treatments. The increasing interest in integrative oncology emphasizes the need to engage stakeholders and to work toward consensus on research priorities and a collaborative research agenda. The Integrative Canadian Oncology Research Initiative initiated a consensus-building process to meet that need and to develop an action plan that will implement a Canadian research agenda.
  
  
  METHODS
  A two-day consensus workshop was held after completion of a Delphi survey and stakeholder interviews.
  
  
  RESULTS
  FIVE INTERRELATED PRIORITY RESEARCH AREAS WERE IDENTIFIED AS THE FOUNDATION FOR A CANADIAN RESEARCH AGENDA: EffectivenessSafetyResource and health services utilizationKnowledge translationDeveloping integrative oncology models Research is needed within each priority area from a range of different perspectives (for example, patient, practitioner, health system) and in a way that reflects a continuum of integration from the addition of a single complementary intervention within conventional cancer care to systemic change. Strategies to implement a Canadian integrative oncology research agenda were identified, and working groups are actively developing projects in line with those strategic areas. Of note is the intention to develop a national network for integrative oncology research and knowledge translation.
  
  
  CONCLUSIONS
  The identified research priorities reflect the needs and perspectives of a spectrum of integrative oncology stakeholders. Ongoing stakeholder consultation, including engagement from new stakeholders, is needed to ensure appropriate uptake and implementation of a Canadian research agenda.
authors.affiliation: Ottawa Integrative Cancer Centre, Ottawa, ON.
authors.forename: L C
authors.initials: LC
authors.lastname: Weeks
authors.forename: D
authors.initials: D
authors.lastname: Seely
authors.forename: L G
authors.initials: LG
authors.lastname: Balneaves
authors.forename: H S
authors.initials: HS
authors.lastname: Boon
authors.forename: A
authors.initials: A
authors.lastname: Leis
authors.forename: D
authors.initials: D
authors.lastname: Oneschuk
authors.forename: S M
authors.initials: SM
authors.lastname: Sagar
authors.forename: M J
authors.initials: MJ
authors.lastname: Verhoef
keywords: Canada; Integrative oncology; cam; complementary medicine; consensus development; research priorities
references.citation: J Nurs Staff Dev. 1994 Mar-Apr;10(2):62-5
references.pmid: 8176489
references.citation: J Soc Integr Oncol. 2006 Winter;4(1):27-39
references.pmid: 16737670
references.citation: Ann Oncol. 2005 Apr;16(4):655-63
references.pmid: 15699021
references.citation: Explore (NY). 2010 May-Jun;6(3):143-58
references.pmid: 20451148
references.citation: Curr Oncol. 2012 Dec;19(6):e436-61
references.pmid: 23300368
references.citation: J Soc Integr Oncol. 2006 Fall;4(4):157-69
references.pmid: 17022924
references.citation: Am J Public Health. 1984 Sep;74(9):979-83
references.pmid: 6380323
references.citation: J Altern Complement Med. 2006 Jun;12(5):459-66
references.pmid: 16813510
references.citation: Cancer. 2008 Sep 1;113(5):1048-57
references.pmid: 18680170
references.citation: J Soc Integr Oncol. 2009 Summer;7(3):85-120
references.pmid: 19706235
references.citation: J R Soc Med. 2001 Nov;94(11):608
references.pmid: 11865448
references.citation: Integr Cancer Ther. 2003 Sep;2(3):212-6
references.pmid: 15035882
references.citation: Complement Ther Med. 2012 Oct;20(5):345-52
references.pmid: 22863650
references.citation: Curr Oncol. 2008 Aug;15 Suppl 2:s83-7
references.pmid: 18769572
references.citation: J Adv Nurs. 2000 Oct;32(4):1008-15
references.pmid: 11095242